• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非离子二聚体碘曲仑的理化性质及一般药理学

Physicochemical properties and general pharmacology of the nonionic dimer iotrolan.

作者信息

Mützel W, Press W R, Weinmann H J

出版信息

Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd. 1989;128:28-32.

PMID:2568804
Abstract

Iotrolan, a nonionic, hexaiodinated dimer, is an extremely hydrophilic compound (P = 0.005). Due to its larger Stokes' radius compared with monomeric compounds such as metrizamide, the diffusion time through membranes is extended. Iotrolan deforms erythrocytes only minimally. There is practically no binding to plasma proteins. The new contrast agent has been shown to exert a very limited effect on the complement system (in vitro); it does not inhibit lysozyme (a standard enzyme) in concentrations less than 100 mg I/ml. To inhibit activity of the enzyme collagenase, much higher concentrations of iotrolan than of metrizamide or iopamidol are needed and this could offer an advantage when used for diskography preceding diskolysis with collagenase. After a single intravenous injection in rats, iotrolan has an LD50 of 28.3 g I/kg - the best general tolerance known for water-soluble contrast media thus far. The superior tolerance of iotrolan compared with iohexol and iopamidol (p less than or equal to 0.05) in rats is statistically significant. On the basis of preclinical experience, iotrolan is a very promising contrast medium for intrathecal and intravascular use.

摘要

碘曲仑是一种非离子型六碘化二聚体,是一种极具亲水性的化合物(P = 0.005)。与诸如甲泛葡胺等单体化合物相比,由于其斯托克斯半径更大,穿过膜的扩散时间延长。碘曲仑对红细胞的变形作用极小。实际上它与血浆蛋白几乎不结合。已表明这种新型造影剂对补体系统(体外)的作用非常有限;在浓度低于100 mg I/ml时它不抑制溶菌酶(一种标准酶)。为抑制胶原酶的活性,所需碘曲仑的浓度比甲泛葡胺或碘帕醇的浓度高得多,而这在胶原酶溶核术前用于椎间盘造影时可能具有优势。在大鼠单次静脉注射后,碘曲仑的半数致死量为28.3 g I/kg——这是迄今为止已知的水溶性造影剂中最好的总体耐受性。碘曲仑在大鼠中与碘海醇和碘帕醇相比具有更高的耐受性(p≤0.05),具有统计学意义。基于临床前经验,碘曲仑是一种非常有前景的用于鞘内和血管内的造影剂。

相似文献

1
Physicochemical properties and general pharmacology of the nonionic dimer iotrolan.非离子二聚体碘曲仑的理化性质及一般药理学
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd. 1989;128:28-32.
2
Tolerance to iotrolan after subarachnoid injection in animals.动物蛛网膜下腔注射碘曲仑后的耐受性
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd. 1989;128:126-33.
3
Tolerance and biochemical pharmacology of iopromide.碘普罗胺的耐受性与生化药理学
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd. 1983;118:11-7.
4
Experimental urography in dogs: diagnostic quality and pharmacokinetic behavior of iotrolan in comparison to nonionic and ionic, monomeric contrast media.犬的实验性尿路造影:与非离子型和离子型单体造影剂相比,碘曲仑的诊断质量和药代动力学行为
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd. 1989;128:82-7.
5
[Preclinical evaluation of iotrolan as a contrast medium for angiography and urography].
Nihon Igaku Hoshasen Gakkai Zasshi. 1992 Sep 25;52(9):1287-98.
6
Hemorrheologic effects of iotrolan after intra-arterial injection in rabbits: comparison with other types of contrast media.碘曲仑动脉内注射对兔血液流变学的影响:与其他类型造影剂的比较。
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd. 1989;128:40-5.
7
[Non-ionic iodinated dimeric versus monomeric X-ray contrast media: effects on complement factors in vivo].[非离子型碘化二聚体与单体X射线造影剂:对体内补体因子的影响]
Rofo. 2006 Mar;178(3):306-12. doi: 10.1055/s-2006-926512.
8
Pharmacokinetics of iotrolan after intravenous injection into healthy volunteers.健康志愿者静脉注射碘曲仑后的药代动力学
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd. 1989;128:211-4.
9
Biochemical-pharmacologic properties of iohexol.碘海醇的生化药理学特性。
Acta Radiol Suppl. 1980;362:111-5.
10
Organ-specific and general tolerance of iotrolan 280 after intravenous administration: phase I study in healthy volunteers.静脉注射后碘曲仑280的器官特异性和全身耐受性:健康志愿者的I期研究
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd. 1989;128:33-8.